Mannich bases of 1,2,4-triazole-3-thione containing adamantane moiety : Synthesis, preliminary anticancer evaluation, and molecular modeling studies
© 2016 John Wiley & Sons A/S..
A series of 18 novel N-Mannich bases derived from 5-adamantyl-1,2,4-triazole-3-thione was synthesized and characterized using NMR spectroscopy and X-ray diffraction technique. All derivatives were evaluated for their anticancer potential against four human cancer cell lines. Several tested compounds exerted good cytotoxic activities on K562 and HL-60 cell lines, along with pronounced selectivity, showing lower cytotoxicity against normal fibroblasts MRC-5 compared to cancer cells. The effects of compounds 5b, 5e, and 5j on the cell cycle were investigated by flow cytometric analysis. It was found that these compounds cause the accumulation of cells in the subG1 and G1 phases of the cell cycle and induce caspase-dependent apoptosis, while the anti-angiogenic effects of 5b, 5e, and 5j have been confirmed in EA.hy926 cells using a tube formation assay. Further, the interaction of Bax protein with compound 5b was investigated by means of molecular modeling, applying the combined molecular docking/molecular dynamics approach.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:89 |
|---|---|
| Enthalten in: |
Chemical biology & drug design - 89(2017), 6 vom: 30. Juni, Seite 943-952 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Milošev, Milorad Z [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
1,2,4-triazole |
|---|
| Anmerkungen: |
Date Completed 03.11.2017 Date Revised 12.10.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/cbdd.12920 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM26695877X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM26695877X | ||
| 003 | DE-627 | ||
| 005 | 20231224215639.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/cbdd.12920 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0889.xml |
| 035 | |a (DE-627)NLM26695877X | ||
| 035 | |a (NLM)27933733 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Milošev, Milorad Z |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Mannich bases of 1,2,4-triazole-3-thione containing adamantane moiety |b Synthesis, preliminary anticancer evaluation, and molecular modeling studies |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.11.2017 | ||
| 500 | |a Date Revised 12.10.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2016 John Wiley & Sons A/S. | ||
| 520 | |a A series of 18 novel N-Mannich bases derived from 5-adamantyl-1,2,4-triazole-3-thione was synthesized and characterized using NMR spectroscopy and X-ray diffraction technique. All derivatives were evaluated for their anticancer potential against four human cancer cell lines. Several tested compounds exerted good cytotoxic activities on K562 and HL-60 cell lines, along with pronounced selectivity, showing lower cytotoxicity against normal fibroblasts MRC-5 compared to cancer cells. The effects of compounds 5b, 5e, and 5j on the cell cycle were investigated by flow cytometric analysis. It was found that these compounds cause the accumulation of cells in the subG1 and G1 phases of the cell cycle and induce caspase-dependent apoptosis, while the anti-angiogenic effects of 5b, 5e, and 5j have been confirmed in EA.hy926 cells using a tube formation assay. Further, the interaction of Bax protein with compound 5b was investigated by means of molecular modeling, applying the combined molecular docking/molecular dynamics approach | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Mannich bases | |
| 650 | 4 | |a adamantane | |
| 650 | 4 | |a anticancer activity | |
| 650 | 4 | |a molecular modeling | |
| 650 | 4 | |a triazoles | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Mannich Bases |2 NLM | |
| 650 | 7 | |a Thiones |2 NLM | |
| 650 | 7 | |a Triazoles |2 NLM | |
| 650 | 7 | |a 1,2,4-triazole |2 NLM | |
| 650 | 7 | |a 288-88-0 |2 NLM | |
| 650 | 7 | |a Adamantane |2 NLM | |
| 650 | 7 | |a PJY633525U |2 NLM | |
| 700 | 1 | |a Jakovljević, Katarina |e verfasserin |4 aut | |
| 700 | 1 | |a Joksović, Milan D |e verfasserin |4 aut | |
| 700 | 1 | |a Stanojković, Tatjana |e verfasserin |4 aut | |
| 700 | 1 | |a Matić, Ivana Z |e verfasserin |4 aut | |
| 700 | 1 | |a Perović, Milka |e verfasserin |4 aut | |
| 700 | 1 | |a Tešić, Vesna |e verfasserin |4 aut | |
| 700 | 1 | |a Kanazir, Selma |e verfasserin |4 aut | |
| 700 | 1 | |a Mladenović, Milan |e verfasserin |4 aut | |
| 700 | 1 | |a Rodić, Marko V |e verfasserin |4 aut | |
| 700 | 1 | |a Leovac, Vukadin M |e verfasserin |4 aut | |
| 700 | 1 | |a Trifunović, Snežana |e verfasserin |4 aut | |
| 700 | 1 | |a Marković, Violeta |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chemical biology & drug design |d 2006 |g 89(2017), 6 vom: 30. Juni, Seite 943-952 |w (DE-627)NLM160848377 |x 1747-0285 |7 nnns |
| 773 | 1 | 8 | |g volume:89 |g year:2017 |g number:6 |g day:30 |g month:06 |g pages:943-952 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/cbdd.12920 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 89 |j 2017 |e 6 |b 30 |c 06 |h 943-952 | ||